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L’importance du bilan initial dans la prise en charge 
des syncopes 
 
 
 
La syncope est un symptôme fréquent, défini comme une perte de connaissance subite 
et transitoire associée à un affaiblissement du tonus postural suivi d’une récupération 
spontanée avec un retour rapide à un état de conscience normal.  Elle peut être causée 
par une multitude de conditions et présente donc un très large diagnostic différentiel 
étiologique.  Il est important de reconnaître la syncope comme un symptôme de ces 
causes et non comme un diagnostic étiologique en elle-même.  
 
La syncope est un phénomène qui a été rapporté à travers l’histoire écrite, et dont le 
mécanisme a pendant longtemps été moins bien compris.  Hippocrate semble avoir été 
le premier à fournir une description d’un patient présentant un épisode syncopal.  
Dérivée du grec synkoptein signifiant "coupé court", elle a continué à être mentionnée 
depuis.  Les avancées les plus remarquables dans la compréhension de la syncope ont 
dû attendre les 19eme et 20eme siècles avec les travaux de John Newport Langley sur le 
système nerveux autonome, d’Albert von Bezold sur l’arc reflex afférent du cœur et 
de Sir Thomas Lewis ayant démontré des épisodes de syncope liés à des hypotensions 
artérielles sans bradycardie. 
 
La syncope a par ailleurs été reconnue comme souvent liée à des pathologies pouvant 
menacer la vie et présageant d’une mort subite.  C’est parce qu’elle peut être 
prédictive d’un mauvais pronostic vital qu’il est crucial que la syncope soit reconnue 
et distinguée d’autres phénomènes qui peuvent parfois se présenter d’une manière en 
partie similaire mais dont le pronostic est autre.  De plus, il est impératif de distinguer 
les causes cardiaques des causes non cardiaques, car les premières on été associées à 
une mortalité plus élevée. 
 I
 Au cours des dernières années, l’intérêt qu’a engendré la syncope n’a cessé de croître, 
probablement en partie dû à sa fréquence relativement élevée et également au taux 
d’hospitalisation qui lui est lié, pouvant représenter jusqu’à 3% des motifs de 
consultations dans un centre d’urgence et de 2 à 6% des causes d’hospitalisation 
toutes confondues.  La syncope survient dans toutes les classes d’âge, avec cependant 
une nette augmentation de prévalence avec l’âge croissant et associée à une morbidité 
traumatique importante.  Le taux de récurrence est également élevé, lié aux causes 
vasovagales et cardiaques. 
 
On retrouve dans la littérature jusqu’au début des années 80 des revues de la 
pathophysiologie ainsi que des descriptions d’entités étiologiques, puis la littérature 
des années 80 à commencé à s’intéresser à l’importance pronostique de 
l’identification des causes sous-jacentes; l’utilité de certains examens diagnostics a 
également fait l’objet d’évaluations.  Cependant, depuis ces études, la démographie de 
la population, l‘augmentation des maladies cardiovasculaires ainsi que l’émergence de 
la revascularisation percutanée associée à la prévention cardiovasculaire secondaire 
ont sans nul doute modifié la valeur de certains de ces résultats et l’épidémiologie de 
la syncope elle-même a sans nul doute évolué. 
 
Les causes sont multiples, mais l’épisode syncopal est ultimement le résultat soit 
d’une diminution de la quantité, soit de la qualité de la perfusion sanguine cérébrale.  
Le métabolisme cérébral est intimement lié à cette perfusion et une interruption 
transitoire d’approximativement 8-10 secondes est suffisante pour induire une perte 
de connaissance.  Le simple changement de la position en décubitus dorsal à la 
position debout peut induire un déplacement de 500 à 800 ml de sang vers l’abdomen 
et les membres inférieurs, suffisant pour diminuer le retour veineux, diminuer en 
conséquence la pré charge et donc le débit cardiaque.  L’hyper contractilité du cœur 
sur des cavités cardiaques moins remplies forme la base du phénomène de Bezold 
Jarish, phénomène qui se produit à travers un arc reflex partant de récepteurs 
cardiaques via des centres nerveux du tronc cérébral, conduisant ultimement à un effet 
paradoxal associant une bradycardie et une hypotension artérielle.  Une partie de cet 
arc reflex est également la base des syncopes vasovagales.   
 II
 L’évaluation des patients est souvent contraignante, comprenant une vaste panoplie 
d’examens cardiovasculaires effectués de manière indiscriminée, menant rarement à 
une amélioration de rendement diagnostique mais dont le coût devient de plus en plus 
élevé.  L’évaluation du coût de la prise en charge des syncopes au Etats Unis en 2005 
s’élève à $2.4 milliards avec $5,400 par hospitalisation.  Au vu de ces coûts 
exorbitants, ce défi diagnostique appelle donc à une approche de la prise en charge 
diagnostique basée sur des preuves, qui pourrait ainsi améliorer le rapport coût-
efficacité de la prise en charge.  Selon les études effectuées durant les années 80 et au 
début des années 90, la proportion des patients avec diagnostic de syncope d’origine 
inexpliqué pouvait varier de 5 à 47%.  Cette variabilité de résultats est due à 
l’hétérogénéité des populations étudiées, du tout venant dans un centre d’urgence aux 
patients des soins intensifs, de centres de santé primaires aux centres tertiaires.  Par 
ailleurs l’utilité diagnostique de l’anamnèse et de l’évaluation initiale a été peu 
étudiée. 
 
C’est dans ce contexte d’augmentation des techniques d’investigations à disposition, 
d’une augmentation de l’incidence des syncopes probablement due en partie au 
changement démographique ainsi que de la nécessité de développer des approches 
diagnostique avec un meilleur rapport coût-efficacité que cette étude a été menée afin 
d’évaluer le rendement diagnostique d’une approche systématisée et standardisée dans 
une population non sélectionnée se présentant aux urgences dans un centre de santé de 
premier recours.  L’étude a également permis d’évaluer le spectre étiologique de la 
syncope dans cette population.  
 
Les patients de 18 ans révolus se présentant à l’Hôpital Cantonal de Genève avec 
comme plainte principale une syncope ont été inclus dans l’étude après avoir obtenu 
leur consentement écrit.  Ils ont subi une évaluation standardisée effectuée aux 
urgences, comprenant une anamnèse détaillée, un examen physique, un 
électrocardiogramme, la recherche systématique d’hypotension orthostatique artérielle 
par un test de Schellong ainsi qu’une recherche d’hypersensibilité des sinus 
carotidiens.  Les données ont été répertoriées dans un protocole servant également de 
rappel aux médecins en charge des patients des critères diagnostiques des diverses 
causes. 
 III
 L’évaluation initiale a permis de classifier les patients en trois groupes: (a) les patients 
chez qui un diagnostic était fortement suspecté; (b) les patients chez qui une cause 
était suspectée sur la base des symptômes et signes mais qui nécessitait une 
confirmation par un examen diagnostique dirigé; et (c) les patients chez qui l’origine 
de la syncope est restée indéterminée après le bilan initial. 
 
Ce dernier groupe a par la suite subi une évaluation cardiovasculaire plus étendue 
avec un monitoring électrocardiographique prolongé à l’aide d’un enregistrement 
Holter et un enregistrement électrocardiographique sur une semaine à l’aide d’un 
"dispositif d’enregistrement en boucle", une échocardiographie transthoracique, 
l’analyse des potentiels tardifs ainsi qu’une épreuve d’orthostatisme prolongé ("Tilt 
test").  Une étude électrophysiologique a été pratiquée chez les patients présentant une 
atteinte cardiaque structurelle, des anomalies électrocardiographiques détectées durant 
le monitoring prolongé ou des potentiels tardifs et ceci selon les recommandations 
actuellement retenues. 
 
Les diagnostics ont été établis selon les définitions reconnues dans la littérature 
médicale, chaque cas ayant été discuté et confirmé selon les critères explicites et 
reproductibles.  Le suivi des patients a été assuré chaque 6 mois pendant les 18 mois 
suivant la date d’inclusion.  Durant la période d’inclusion, 788 patients ont été admis 
aux urgences pour syncope, dont 650 ont pu être inclus. 
 
Les résultats ont démontré qu’il est possible d’assigner une cause chez presque 70% 
des patients se présentant aux urgences avec une syncope sans l’utilisation étendue 
d’examens complémentaires.  En particulier, l’anamnèse et l’examen clinique, 
associés à la recherche systématique d’hypotension artérielle orthostatique ont prouvé 
avoir le meilleur rendement, permettant de poser un diagnostic et évitant une prise en 
charge inappropriée.  Le suivi médical a de plus confirmé une mortalité presque 
doublée chez les patients présentant une syncope d’origine cardiaque par rapport à 
une cause non cardiaque ou inexpliquée.  En outre, le rendement diagnostique des 
examens complémentaires cardiovasculaires été plus élevé dans le sous-groupe de 
patients chez qui une "anomalie" anamnestique, clinique ou electrocardiographique 
avait été décelée durant le bilan initial. 
 IV
 Cette étude indique l’importance d’une évaluation initiale bien conduite et montre que 
l’efficacité de celle ci est améliorée par l’utilisation d’un protocole d’évaluation 
standardisé, rappelant les critères diagnostics, ainsi qu’une application rigoureuse de 
ces critères, semble donc être cruciale pour une approche diagnostique offrant un 
avantage en terme de rapport coût efficacité, diminuant l’utilisation d’examens 
complémentaires qui s’avèrent peu rentables s’ils ne sont pas dirigés.  Par ailleurs 
cette évaluation permet également de diminuer le nombre de patients dont l’origine de 
la syncope reste indéterminée. 
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CHAPTER 1  SUMMARY 
 
 
1.0 Summary 
 
1.1 Abstract 
 
 
Syncope is a common symptom, defined as a sudden loss of consciousness and 
postural tone with spontaneous recovery. It is caused by a wide spectrum of 
etiological entities, all resulting in a decrease in the quantity or quality of cerebral 
perfusion. Syncope has been reported throughout recorded history, for a long time less 
well understood, but having been recognized as often heralding sudden death. 
Because it can be predictive of life-threatening conditions, it is important that syncope 
be distinguished from other entities that may have be similar in presentation but 
which nevertheless present a benign prognosis. Furthermore it is imperative to 
distinguish between cardiac and non cardiac causes as the former have been shown to 
be associated with the highest mortality. Interest in syncope has grown significantly in 
recent years, probably because of its relatively frequent occurrence and the fact that 
the incidence of patients hospitalised as a result of it is high, representing up to 3% of 
emergency room visits and from 2-6 % of all hospital admissions. Although syncope 
occurs in all age groups, its incidence increases with age. Furthermore the evaluation 
of such patients is often fastidious with broad ranging cardiovascular testing often 
been practiced indiscriminately in all patients, rarely leading to a significant increase 
in diagnostic yield, but resulting in an ever increasing cost. The problem therefore 
calls for evidence-based approaches to its diagnosis and management. Initially 
reviewing the pathophysiology and descriptions of individual etiological entities, the 
literature in the 1980’s began reviewing the prognostic importance of identifying the 
underlying cause and the relative usefulness of certain diagnostic tests. Since then 
however, the general demography of patients, the increase in cardiovascular disease 
but also the emergence of frequent coronary revascularisation and cardiovascular 
secondary prevention has almost certainly changed the overall epidemiology of 
syncope. In this context, this study aimed to evaluate in a primary care centre the 
etiological spectrum of syncope in a non selected population and to further evaluate 
the diagnostic yield of a systematic and standardized initial workup protocol. The 
study demonstrated that up to 70% of patients presenting to an emergency room with 
syncope could have a likely cause of syncope ascribed without the use of extensive 
complementary exams. The initial history and physical examination appeared to be of 
most important value offering the highest diagnostic yield. Systematic search for 
orthostatic hypotension showed the second highest yield. Using a standardized 
protocol focusing on these aspects as well as acting as a reminder of specific disease 
diagnostic criteria and a rigorous application of these criteria appears key to a cost-
effective workup of syncope and decreases the number of patients with syncope of 
undetermined origin. 
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1.2 Résumé 
 
 
La syncope est un symptôme fréquent, défini comme une perte de connaissance subite 
et transitoire associée à un affaiblissement du tonus postural suivi d’une récupération 
spontanée avec un retour rapide à un état de conscience normal.  Les causes sont 
multiples, toutes menant ultimement à une diminution, soit de la quantité, soit de la 
qualité de la perfusion sanguine cérébrale.  La syncope est un phénomène qui a été 
rapporté à travers l’histoire écrite, et dont le mécanisme a pendant longtemps été mal 
compris, mais qui à été reconnue comme souvent présageant d’une mort subite.  C’est 
parce qu’elle peut être prédictive d’un mauvais pronostic vital, qu’il est important que 
la syncope soit reconnue et distingué d’autres phénomènes qui peuvent parfois se 
présenter d’une manière en partie similaire mais dont le pronostic est autre.  De plus, 
il est impératif de distinguer les causes cardiaques des causes non cardiaques, car les 
premières on été associées à une mortalité plus élevée.  Au cours des dernières 
années, l’intérêt qu’a engendré la syncope n’a cessé de croître, probablement en partie 
dû à sa fréquence relativement élevée et également au taux d’hospitalisation qui lui 
est lié, pouvant représenter jusqu’à 3% des motifs de consultations dans un centre 
d’urgence et de 2 à 6% des causes d’hospitalisation toutes confondues.  La syncope 
survient dans toutes les classes d’âge, avec cependant une nette augmentation de 
prévalence avec l’âge.  De plus, l’évaluation de ces patients est souvent contraignante, 
comprenant une vaste panoplie d’examens cardiovasculaires effectués de manière 
indiscriminée, menant rarement à une amélioration de rendement diagnostique mais 
dont le coût devient de plus en plus élevé.  Ceci appelle donc à une approche de la 
prise en charge diagostique basée sur des preuves.  Après avoir revu la 
pathophysiologie et présenté des descriptions d’entités étiologiques, la littérature des 
années 80 a commencé à s’intéresser à l’importance pronostique de l’identification 
des causes sous-jacentes à la syncope et de l’utilité de certains examens 
diagnostiques.  Cependant, depuis ces études, la démographie de la population, 
l‘augmentation des maladies cardiovasculaires ainsi que l’émergence de la 
revascularisation percutanée associée à la prévention cardiovasculaire secondaire ont 
sans nul doute modifié l’épidémiologie de la syncope.  C’est dans ce contexte que 
cette étude a été menée afin d’évaluer le spectre étiologique de la syncope dans une 
population non sélectionnée se présentant dans un centre de santé de premier recours. 
L’étude a également évalué le rendement diagnostique d’une approche systématisée et 
standardisée.  Elle a démontré qu’il était possible d’assigner une cause chez presque 
70% des patients se présentant aux urgences avec une syncope comme motif de 
consultation sans l’utilisation large d’examens complémentaires.  L’anamnèse et 
l’examen clinique, associés à la recherche systématique d’hypotension artérielle 
orthostatique ont prouvé avoir le meilleur rendement.  L’utilisation d’un protocole 
d’évaluation standardisé, prêtant attention à ces aspects et rappelant les critères 
diagnostiques, ainsi qu’une application rigoureuse de ces critères, semble être cruciale 
pour une approche diagnostique offrant un avantage en terme de rapport coût 
efficacité.  Par ailleurs elle permet également de diminuer le nombre de patients dont 
l’origine de la syncope reste indéterminée. 
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2.0 Introduction 
 
 2.1 Background 
 
 
Syncope is defined as a sudden loss of consciousness and postural tone with 
spontaneous recovery.  It can be caused by a multitude of underlying conditions and 
thus has a large differential diagnosis.  It is crucial to understand syncope as a 
symptom of these conditions and not as a diagnosis in itself.  In syncopal episodes, 
loss of consciousness is ultimately the result of a transitory decrease in the quantity or 
quality of cerebral perfusion.  Because it can be predictive of life-threatening 
conditions, it is important that syncope be distinguished from other entities that may 
have a similar presentation but which are nevertheless not indicative of life-
threatening problems.  In particular those which are not strictly characterized by a loss 
of consciousness, such as vertigo, dizziness and light-headedness, those without 
spontaneous recovery, such as prolonged hypoglycaemia, and from entities such as 
generalized tonic clonic seizures. 
 
Furthermore, the literature shows that establishing the cause of syncope is essential 
for several reasons.  The first is the fact that mortality and morbidity is increased in 
patients with an underlying cardiac cause as compared to patients with a non-cardiac 
or unknown cause. Syncope can thus be disabling and a forewarning of sudden death.  
The second is that although a number of complementary exams are available in the 
workup of syncope, the literature up until the 1990’s was replete with controversy 
about the diagnostic usefulness of specific diagnostic tests and identifying high risk 
patients remains difficult. 
 
Interest in syncope has grown significantly in recent years.  There are probably a 
number of reasons for this.  The first is its relatively frequent occurrence and the fact 
that the incidence of patients hospitalised as a result of it is high.  Syncope represents 
up to 3% of emergency room visits and from 2-6 % of all hospital admissions [1].  
Although syncope occurs in all age groups, its incidence increases with age and in 
industrialised and post industrialised countries where the denominator of people 
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potentially at risk of syncope has grown dramatically, the problem calls for evidence-
based approaches to its diagnosis and management [2]. 
 
It is in this context that we conducted a study aimed at evaluating the diagnostic yield 
of a systematic and standardized initial workup protocol in a primary care centre in a 
non selected population which is the focus of this thesis. The study was also designed 
to further evaluate the etiological spectrum as well as determine the usefulness of 
further cardiovascular testing the results of which have been published [3-6]. 
 
 
2.2 Historical interest in syncope 
 
 
Syncope has long presented a diagnostic interest and challenge to medicine. It appears 
that Hippocrates was the first to provide a description of a patient a syncopal episode 
[7, 8]. Deriving from the Greek synkoptein meaning “to cut short”, it has continued to 
be mentioned and researched since then.  Evidence of continuing interest in syncope 
in the Middle Ages comes from descriptions of Tanswuth (dancing mania) “in which 
music caused victims to dance until they fainted..” and “…stimulating music and fits 
of wild dancing, leaping, hopping and clapping that ended in syncope” [9, 10].  
Physicians at that time described and documented a variety of classic symptoms such 
as hyperventilation, tachycardia, palpitations, histories of recent food deprivation and 
lack of sleep.  They characterised syncope at the time as predominantly affecting 
young unmarried women.   
 
The role played by emotions in syncope has also been an area of interest, and 
references to emotional faints and spells have been found in ancient Egyptian paperii.  
In the 18th century Robert Whytt argued that “nervous connections mediated all 
sensations, motions, and other functions”, enabling “strong passion to cause a fit” 
with a vision of “the unity of the body and the mind as mediated by the nervous 
system”, thus permitting the role of emotions in syncope to be seen for the first time 
in a physiological manner [11]. 
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Caleb Hillier Parry’s 1799 work on syncope anginosa, however, placed the cause of 
syncope within the cardiovascular system and “thus took syncope out of the head and 
into the body”, changing the belief that the circulatory changes during syncope were 
the effect of an ill-defined disturbance of the cerebral hemispheres.  He proposed that 
the origin of syncope was in the arterial system and that the “…brain is affected only 
secondarily, in consequence of the want of blood determined to it by the heart. It is 
true indeed, that certain sensations and passions, as we have before observed, produce 
Syncope; and as these are affections of the mind, it is obvious that the original 
operation of the causes producing them is on the brain, But I contend that they would 
not occasion Syncope, without an intermediate and corresponding diminution of the 
action of the heart and the arteries, operating in a manner which I have already 
explained. In other words, the brain is in these cases nothing more than the medium of 
sensation to the arterial system, which is then effected with that inaction which 
constitutes Syncope”.   
 
With the discovery by Le Gallois and Bichat that the rhythmicity of the heart was 
modulated by nervous influence and that there was both sensory and sympathetic 
myocardial innervations, a neurogenic theory of heart function emerged.  This was 
supported by experiments in the 18th centrury by the Weber brothers that showed the 
slowing of the heart by galvanomagnetic stimulation of the vagus nerve.  A reflex arc 
theory was developed that explained the cardioinhibitory effects of a series of stimuli 
(see pathophysiology) and after these initial experiments demonstrating a neural 
control of the heart, interest in the site of afferent signals and receptors in the heart, 
great vessels and lungs [11] grew rapidly. 
 
During the so-called golden age of Irish medicine in the 19th century, two physicians, 
Robert Adams and William Stokes, characterised what later would be referred to as 
Stokes-Adams attacks, that involved unpredicted collapses associated with a loss of 
consciousness lasting a few seconds [12].  They described patients as being initially 
pale but then becoming flushed on recovery.  In “Observations of some cases of 
permanently slow pulse” [13], Stokes cited one of Adams’ 1827 descriptions of a case 
of syncope (published in 1846) which was associated with bradycardia. Typically 
associated with complete heart block, Stokes-Adams attacks have also been referred 
to as the tachy-brady syndrome [14]. 
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Around the same period the novelist, Sir Arthur Conan Doyle made numerous 
mentions of conditions involving seizures, stroke and syncope, ascribing a particular 
power of observation an deductive reasoning to his most famous detective, Sherlock 
Holmes [15]. 
 
While working as a house officer at Guy’s Hospital London in 1873, Alfred Lewis 
Galabin went on to document atrioventricular block and using an apexcardiogram was 
able to demonstrate atrioventricular block graphically.  He presented his findings in a 
case report [16] of a 34 year old patient who he described as having had a number of 
attacks of “faintness” or near syncope.[17]  Early clinical observations of the practice 
of blood letting also provided additional insights into the mechanisms of syncopal loss 
of consciousness and more specifically the combined effect of both decreased heart 
rate and blood pressure [11].  Research in this area went on to permit a better 
understanding of the neuroanatomic connections between the brain and the heart, and 
more specifically the glossopharyngeal (IX) the vagus (X), and the accessory (XI) 
cranial nerves as well as the sympathetic chain), which under some form or other had 
been described since the time of Galen of Pergamon (AD 129-199).  
 
Meanwhile a series of parallel discoveries by John Newport Langley in 1898 led him 
to introduce the term “autonomic nervous system” [18].   Nahm’s article on syncope 
and the history of nervous influences on the heart [11], states that “…the first 
experimental studies regarding syncope were primarily structural and largely based on 
neuro-anatomic connections between the heart and the brain…”.  It was not until the 
19th century, when electrophysiological methods allowed a more functional study of 
the nervous influences on the heart and their effect on syncopal events, that a more 
comprehensive view emerged than had been possible using observations of 
bloodletting. 
 
Studies conducted as early as 1866 had described a depressor nerve that was thought 
to originate in the heart and to have negative effects on both heart rate and blood 
pressure when stimulated at its central end.  Albert von Bezold and a colleague 
showed that “injections of veratrine into the ventricles of experimental animals 
produced a powerful depressor effect” [11] and a century later, in 1949, studies by 
Jarish and colleagues [19], showed that “the depressor reflex was conducted via 
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afferent fibres that originated in the ventricles”.  They described thin, unmyelinated C 
fibres, and postulated that these fibres were part of a nociceptive reflex mediating the 
decrease in blood pressure due to the veratrine injections of von Bezold.  The 
decrease in blood pressure resulting from the stimulation of ventricular depressor 
afferents is today referred to as the Bezold-Jarisch effect. Later experiments went on 
to suggest that large pressure gradients generated when the ventricular muscle 
contracts on an empty chamber stimulated these fibres. 
 
Eventually it was suggested that syncopal episodes could result from both a vagally 
mediated reflex bradycardia and a mixed vasodepressor and bradycardic response due 
to afferent signals often originating from the left ventricle as well as from non cardiac 
sites, such as the carotid artery and aorta.  The latter was demonstrated through 
research with heart transplant patients, where there was no re-innervation.  This 
notion that as well as being an effector, the heart is equally an afferent source of 
stimuli in syncopal episodes forms the basis for the use of ß-blockers in the treatment 
of certain patients. 
 
In the late 19th century, Sir William R Gower described patients’ “pallor and 
coldness” associated with “symptoms, such as epigastric, respiratory, and cardiac 
discomfort” leading to vasomotor spasms [20] and then the “ return of strength to the 
pulse and of colour to the face”.  His understanding of the pathophysiology of 
syncope and in particular neurocardiogenic syncope was nevertheless wrong, even 
though his term “vasovagal” remains in use today [21].  Vasovagal syncope is now 
recognized as the entity redefined and characterized by Sir Thomas Lewis, founder of 
the journal Heart in 1909, in his 1918 article on fainting attacks [22, 23]. His studies 
of young soldiers suffering from “irritable heart” condition demonstrated that 
hypotension could not systematically be attributed to bradycardia, and after studying 
the clinical significance of syncopal episodes without associated bradycardia he 
reported what he described was a pathophysiological mechanism and in so doing 
generated new interest into the neural control of blood pressure. 
 
Despite the progress made in understanding syncope, it is noteworthy that an overall 
view of the pathophysiology of neurally mediated syncope was not put forward until 
the mid 20th century.  Brown-Séquard and others in the mid 19th century had 
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postulated that blood pressure was not merely a result of decreased cardiac output 
resulting from bradycardia, but was also independently controlled by a distinct system 
of sympathetic vasomotor nerves.  They had suggested that a “depressor reflex” had 
two distinct pathways, one stimulating the vagus nerve leading to bradycardia, the 
other leading to the inhibition of vasomotor centres in the medulla, thus leading to 
vasodepression.  It was not until much later that advances in medicine and 
investigative procedures went on to shed light on the range of cardiovascular causes 
of syncope.   
 
Of all cardiac causes, heart block is now felt to account for only a small minority of 
syncope events, while arrhythmias and obstructive causes are recognized as 
responsible for most.  Notably, the diagnostic classification of the aetiology of 
syncope has meant that previously described incidents such as Stokes-Adams attacks 
now have specific causes ascribed to them.  Of interest, however, slow heart rates are 
now associated with decreased arterial blood flow, reduced myocardial contractility 
and subsequent reduced tissue perfusion that contributes to symptoms of both cerebral 
and myocardial ischemia (sometime leading to death), corresponding to the classical 
Stokes-Adams attack [24, 25].  Today, both cardiac as well as central nervous afferent 
signals are known to lead to syncope by affecting parallel efferent pathways leading 
to “differential degrees of reflex bradycardia and hypotension” [11], and it is this 
consideration that is at the centre of the classification of various neurocardiogenic 
responses to tilt-table testing. 
 
 
2.3 Definition of syncope and distinguishing it from seizures 
 
 
Recognizing syncope is primordial in clinical settings.  Efficient diagnosis can guide 
both the initial evaluation and further workup [26]. In a two step process, syncope as 
defined by a transient loss of consciousness, has to be identified and an underlying 
cause established as quickly as possible. 
 
Differentiating syncope from epileptic seizures is a common problem in emergency 
room and clinical practice settings in general.  Convulsions are an integral aspect of 
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the brain’s response to hypoxia and the latter has potent epileptogenic effects.  
Reported frequencies vary, but most reports obtained from prospective studies with 
recorded syncopal events suggest that between 70%-90% of syncopal episodes [27, 
28] are associated with convulsions. The fact that they are less frequently documented 
by eyewitnesses probably reflects the fact that they tend to be brief and of variable 
intensity.  In contrast to epileptic related muscle activity, syncopal myoclonic 
movements are not rhythmic and are rarely sustained for more than 30 seconds.  The 
tonic muscle activity is usually mild and does not resemble the forced extensor 
posturing of a generalized tonic clonic seizure.  Very little evidence exists to suggest 
that syncopal convulsions reflect epileptic activity [29].  Muscle activation during 
syncope appears to be subcortical and probably originates from abnormal discharges 
in the reticular formations in the lower brain stem [30]. 
 
Clinically, eyes remain open during syncope, as in epileptic seizures but not in 
psychogenic fits.  However, complex movement automatisms are less frequent in 
syncope, but when they are present they tend to be brief and less repetitive.  Postictal 
confusion is discriminatory for epileptic seizures with postictal disorientation lasting 
more than 30 seconds suggesting the latter.  Tongue bites can be present in both, but 
predominate in epilepsy.  Urinary incontinence and head injury appears equally in 
both groups. Furthermore there is often a precipitating event in syncopal events; this 
occurs rarely in generalized tonic clonic seizures.  A study of 671 patients using a 
“Syncope Symptom Study” questionnaire, established a simple point score based on 
elements of the history and has been suggested as capable of distinguishing syncope 
form seizures [31], but this has yet to be prospectively validated.  A previous 
prospective study of 94 consecutive patients was nevertheless able to identify features 
of the history such as post-event disorientation in favour of seizure, and preceding 
nausea or sweating in favour of syncope [32]. 
 
Although some features of syncope may appear “epileptic” but are non-epileptic 
pathophysiologically, in rare cases, predominantly in children, syncopal and epileptic 
mechanisms have been reported to interact and thus be active concomitantly. In 
situations such as these the underlying cause leading to syncope may secondarily lead 
to an epileptic seizure. 
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Further elements of interest are the common accompanying cardiac arrhythmias in 
temporal lobe epilepsy; these are, however, rarely sufficiently severe to lead to 
syncope.  It has been suggested that certain seizure foci (particularly in the temporal 
lobe) can result in clinical scenarios similar to syncope, especially mimicking 
vasovagal syncope.  Confirming these diagnoses is difficult and may indeed be 
impossible [33]. 
 
 
2.4 Epidemiologic considerations 
 
 
Data from industrialised countries where reporting is thorough suggest that syncope is 
a widespread clinical problem.  In these countries it accounts for approximately 3% of 
all hospital emergency visits, and 1-6 % of a general hospital’s medical admissions 
[34-38]. Although there has been little research on any geographical variations in its 
incidence and prevalence, syncope appears to be a common occurrence in most ethnic 
groups, although syncope in different ethnic subgroups may have different etiological 
spectrum. 
 
According to some sources, up to 30% of adults are thought likely to present an 
episode of syncope to at some point in their lives.  Age variations are nevertheless 
evident and two incidence peaks are discernable, one in the 15-19 year old age group 
and one in the 60-70 year old group.  The most common age at which patients first 
present with syncope of vasovagal origin tends to be around 13 years [39], but 
syncope increases with age [40, 41] and is generally associated with morbidity 
secondary to accidental falls [42]. Gender differences have also been reported; some 
studies suggest that women may be more at risk, while other studies such as the 
Framingham one, suggested a more balanced gender incidence [41]. 
 
Syncope is more common among elderly people and in elderly patients is more likely 
to be associated with more serious co-morbidity than in younger people.  One study of 
711 patients with an average age of 87 found an incidence of 6% per year and a 
prevalence of 23% over 10 years, with a recurrence rate of up to 13 % and relatively 
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high mortality.  However, because elderly people are more likely to present with 
several chronic illnesses as well as being on several medication regimens, including 
drugs for hypotension, it is often difficult to attribute a single cause to syncopal 
episodes [43].  An age-specific evaluation of syncope in a group of 210 elderly 
patients with a mean age of 71 years, and 190 younger patients, found that overall 
mortality and incidence of sudden death was similar in both groups.  However in 
elderly people with a diagnosis of non-cardiovascular and unknown cause, mortality 
and incidence of sudden death was higher[44].  
 
An evaluation of the incidence and prognosis of syncope due to specific causes 
among participants in the Framingham Heart Study (1971 to 1998) [41, 45, 46] also 
revealed that for people with a mean age of 51 years, the overall incidence of first 
reported syncope was 6.2 per 1000 person-years.  This increased with age, producing 
a sharp spike around 70 years.  The age-adjusted incidence rate of syncope among 
people with cardiovascular disease was nearly twice that among participants free of 
cardiovascular disease. The overall incidence of syncope in men and women was 
similar.  Overall mortality was 30% higher among participants with syncope that 
those without.  Cardiac-related syncope doubled the risk of death from any cause, and 
was also associated with an increased risk of fatal and nonfatal cardiovascular events. 
Identifying prognostic factors is therefore of primordial importance. 
 
 
2.5 Economic aspects of syncope 
 
 
A number of factors have contributed to the growth of costs associated with syncope.  
Health care costs in general have increased significantly in all industrialised and post-
industrialised countries and costs associated with the diagnosis and treatment of 
patients presenting with syncope is no exception to this.  In the USA, the cost in 1982 
was estimated to be in the order of $800 million per year, and in 1993 the average 
annual cost incurred for people admitted with syncope but then discharged with 
another diagnosis was $4,942[47].  The average annual cost of managing patients with 
recurrent syncope considered to be of unknown origin was $5,165 in the 1980’s.  
 11
CHAPTER 2  INTRODUCTION 
 
Since then cost have grown considerably.  The direct medical costs of syncope-related 
hospitalizations in the United States was re-evaluated in 2005 [48], with a staggering 
figure of $ 2.4 billion being suggested, and a mean cost on $ 5,400 per hospitalisation.  
In Europe the cost of diagnosis and treatment of patients presenting with syncope and 
then admitted to cardiology units has been estimated at 11,158 € Euros; the highest 
costs are associated with cases secondary to ventricular arrhythmias [49]. 
 
The cost of care is largely associated with the work-up which is typically extensive, 
fastidious and often fails to improve the diagnostic yield or reduce the rate of 
recurrence of syncope.  A review in 1982 [50] carried out at a tertiary care centre, 
estimated that up to $16,000 of unnecessary diagnostic testing may be being 
performed on patients who ultimately receive a diagnosis of vasovagal syncope, 
further reinforcing the fact that establishing a diagnosis is difficult in many cases.  A 
more recent study [51] of the cost implications of two testing strategies in patients 
with unexplained syncope compared a conventional workup with a prolonged 
monitoring one, using an implantable loop recorder.  The results show that a 
conventional strategy has a lower diagnostic yield at a greater cost per patient and a 
greater cost per diagnosis than a primary monitoring strategy ($ 7,891 as compared to 
$ 5,875).  
 
About 10% of falls in the elderly are due to syncope, and serious injury is more 
frequent when syncope precedes the fall.  The cost of treating falls in the elderly 
exceeds $7 billion annually in the United States [43] and is likely to grow in all 
countries.  
 
Establishing a cost effective and clinically rational evaluation protocol as well as 
safely limiting certain syncope-related admissions may ultimately allow substantial 
health care cost savings. 
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3.0 Causes and prognosis of syncope 
 
3.1 Etiological spectrum of syncope 
 
In addition to the historical descriptions of syncope and the research done on its 
pathophysiology prior to the 1980’s there has been a significant and steady growth of 
interest in the natural history of the phenomenon [1, 35, 38], which is often related to 
its aetiology. Conceptually, causes of syncope can be distinguished between those that 
produce a quantitative and those that produce a qualitative decrease in cerebral 
perfusion.   
 
The epidemiology and pathophysiology of syncope point to a category of conditions 
where decreased cardiac output and/or a systemic hypotension can produce cerebral 
hypoperfusion and eventual loss of consciousness.  This category of causes result in a 
quantitative decrease in cerebral perfusion and includes conditions that decrease 
cardiac output, such as certain cardiomyopathies, pulmonary embolus as well as 
conditions resulting in hypotension as in the case of neurally mediated syncope or 
drug induced hypotension.  It also includes conditions that lead to an impossibility of 
increased cardiac output, such as structural heart diseases (for example aortic stenosis 
and obstructive cardiomyopathies) and conditions that lead to the loss of peripheral 
vascular tone and anomalous central nervous vasculature or increased resistance. 
 
The causes resulting in a qualitative decrease of cerebral perfusion include metabolic 
conditions such as hypoglycaemia, hypocapnia (which can contribute to induced 
cerebral vasculature vasoconstriction) and hypoxic conditions such as intra or extra-
cardiac shunts (although rarely leading to complete loss of consciousness). 
 
The overall classification of syncope is typically based on such etiological subgroups 
that encompass, inter alia, vascular, cardiac, non cardiac, neurological, metabolic and 
psychiatric substrates. 
 
The literature suggests (see table 1) that the most common causes to be listed to date 
are vasovagal syncope (1% to 30%), situational syncope (1% to 8%), orthostatic 
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hypotension (4% to 12%) and drug-induced syncope (2% to 9%).  Structural heart 
disease accounts for 3% to 11% and arrhythmias from 5% to 30% of causes. The 
range of percentages and subsequent uncertainty of these figures are based on the fact 
that previous studies have been conducted in heterogeneous settings, from primary 
care centres to tertiary care referral centres, often not distinguishing younger form 
elderly populations. 
 
 
Table 1 Clinical spectrum and major causes of syncope 
 
 
  Relative frequency 
Range (%) 
   
Reflex mediated Neurocardiogenic: 
   - Neurally mediated syncope 
   - Situational 
   - Carotid sinus hypersensitivity 
8-56 
   
Vascular Orthostatic: 
   - Hypovolemia 
   - Drug induced 
   - Autonomic insufficiency 
2-24 
 Subclavian steal  
   
Organic heart 
disease 
Obstructive: 
   - Aortic stenosis 
1-8 
    - Hypertrophic cardiomyopathy  
    - Mitral stenosis  
    - Atrial myxoma  
    - Pulmonary embolus  
    - Pulmonary hypertension  
   
Arrhythmic 
hearts disease 
Arrhythmias: 
   - Bradyarrhythmias/AV block/SND 
   - Supra and ventricular tachyarrhytmias 
4-38 
   
Miscellaneous Neurologic (Seizures/TIA) 3-32 
 Metabolic (Hypoxemia/hypoglycaemia)  
 Psychogenic  
   
Syncope of 
unknown origin 
 13-41 
 
Adapted from [43, 52, 53]. 
AV block:  refers to high degree atrioventricular conduction block, TIA: refers to 
transient ischemic attacks, SND: refers to sinus node dysfunction 
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3.2 Pathophysiology 
 
3.2.1 Mechanisms of syncope 
 
 
Although the etiological spectrum of syncope is wide, the fundamental cause of 
syncope is a decrease in quantitative or qualitative cerebral perfusion, with in the 
former situation, loss of consciousness resulting from a reduction of blood flow to the 
reticular activating system located in the brain stem. The metabolism of the brain is 
particularly dependent on perfusion and a transient interruption of cerebral blood flow 
of approximately 8-10 seconds is sufficient to induces loss of consciousness [35, 54].  
A non reversed decrease of the systolic blood pressure under 60-70 mmHg, or of the 
mean pressure under 30-40 mmHg can provoke a decrease in cerebral perfusion 
followed by syncope [35]. 
 
Conditions leading to hypotension, and in particular hypovolemia, shifts in blood beds 
such as occurs in post-prandial conditions with visceral blood pooling (accentuated by 
decreased muscle tone, such as in upright tilt testing) and hypotensive drugs, increase 
the probabibilty of decreased brain perfusion and thus syncope. The simple changing 
of position from the decubitus position to the upright standing one results in a shift of 
500 to 800 ml of blood to the abdomen and lower extremities resulting in an 
important reduction in venous return to the heart, and a decrease in the pre-charge and 
cardiac output. The resulting reflex arc leading from baroreceptors to an increased 
sympathetic outflow is designed to increase heart rate, cardiac contractility and 
vascular resistance [54]. Any defect in this blood pressure control system or any 
factor altering its integrity increases the probability of a decrease in blood pressure 
sufficient to cause a loss of consciousness.  The cardiac causes of syncope, both 
arrhythmic as well as obstructive lesions, all tend to decrease cardiac output.  Some of 
them do so sufficiently that even alone they produce a decrease in cerebral blood 
flow; others do so through a combination of decreased blood pressure and the reflex 
arc described above. 
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Age-related physiological changes also predispose to syncope by leading to the 
sudden reduction in the supply of oxygen delivered to the brain. These include lack of 
auto-regulation of cerebral blood flow, abnormal vascular reactivity, endothelial 
dysfunction and changes in the sympathetic nervous system (increased plasma levels 
of norepinephrine due to greater spillover from sympathetic nerve terminals and a 
reduced clearance rate, diminished B-adrenergic mediated cardioacceletory response). 
Cerebral blood flow, which decreases with age, renders elderly patients particularly 
susceptible to syncope [43, 55, 56]. 
 
 
3.2.2 Neurally mediated syncope 
 
Vasovagal syncope (also known as neurally mediated, neuro-cardiogenic or 
vasodepressor syncope) represents the most frequent cause of syncope in patients with 
or without structural heart disease. A review of its specific pathophysiology is 
therefore important. As indicated above in the historical perspective, the reflex-
mediated syncopes are based on a reflex arc with an afferent limb and an efferent 
response limb. The response component is common to all of this group of entities 
with a resulting increase in vagal tone and a decrease in the peripheral sympathetic 
tone leading to bradycardia, vasodilation, hypotension and ultimately to loss of 
consciousness.  The classification of the neurally mediated syncopal entities is based 
on the different afferent limbs and their mechanisms of activation of mecano, baro or 
other neural receptors all of which are able to trigger the reflex arc [57-59]. 
 
Different situational syncopal entities are defined by the location of the trigger such as 
in the bladder in micturition syncope, gut wall in defecation syncope, upper 
gastrointestinal tract in deglutition syncope and in the carotid sinus in carotid sinus 
hypersensitivity.  They all lead to hypotension with or without bradycardia.  
Emotional impulses (involving higher neural centres) resulting from acute stress 
situations and impulses from pain, prolonged standing, extreme fatigue or warm 
environments can lead to a decrease in ventricular filling through venous pooling and 
/or an increase in catecholamine secretion [54].  A paradoxical reflex is initiated by a 
left ventricle contracting vigorously on a reduced blood volume leading to the 
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stimulation of non-myelinated C-fibres from the heart and pulmonary outflow tract, 
leading to the dorsal vagal nucleus of the medulla and a paradoxical reduction of 
peripheral sympathetic tone and an increase in vagal tone leading to vasodilatation 
and bradycardia (the classical Bezold-Jarisch phenomenon) (see figure 1) 
 
The reflex arc is thus triggered by excessive afferent discharge from the receptors 
resulting in a rise in parasympathetic efferent activity causing bradycardia and parallel 
inhibition of the sympathetic system leading to concomitant arterial vasodilation and 
hypotension.  It has been postulated that central nervous system modulators such as 
serotonin, adenosine, opioids, endorphins and others may be active in vasovagal 
syncope.  Nitric oxide has also been implicated in the vasodilatory response 
associated with vasovagal syncope [57]. 
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Figure 1 Pathophysiologic basis for neurocardiogenic syncope 
 
 
 
Mechanisms for various reflex-mediated vasomotor syndromes, showing similarities 
and differences in the mechanisms of the entities. IX and X refer to the ninth and 
tenth cranial nerves; PS and S to the parasympathetic and sympathetic nervous 
systems respectively. Adapted from [60-62] 
Emotional 
faint 
Arterial and 
cardiopulmonary 
baroreceptors 
Carotid sinus 
syncope 
Cough syncope 
Exercise-induced 
Head-upTilt 
Higher centers 
(cortex) 
Spinal cord Vagus 
(X) 
Airway 
stimulation 
Swallow 
syncope
GI tract and 
bladder 
(micturition) 
stimulation 
Cardiac and/or 
cardiopulmory 
baroreceptors 
Cranial 
nerves 
V, VII, VIII 
GI/GU 
mechano-
receptors 
Brain stem 
 
Nucleus Tractus Solitarius 
& Medullary vasodepressor 
Higher centers 
& limbic system 
(cortex) 
IX/X 
 
SYNDROMES 
 
 
 
 
 
 
 
 
 
 
 
 
PRINCIPAL 
AFFERENT 
PATHWAYS 
 
 
 
 
 
 
 
 
BRAIN STEM 
 
 
 
 
 
 
 
PSÏ SÐ 
Bradycardia Vasodilatation 
PRINCIPAL 
EFFERENT 
PATHAYS 
Syncope 
 18
CHAPTER 3  CAUSES AND PROGNOSIS OF SYNCOPE 
 
 
 
3.3 Prognosis and risk stratification of syncope 
 
 
Kapoor [63] showed that patients with syncope can be subdivided into diagnostic 
categories that have a prognostic importance.  Notably, patients with a cardiovascular 
cause have a higher incidence of sudden death than patients with a noncardiovascular 
or unknown cause. 
 
In itself, syncope is not a risk factor for increased overall and cardiac mortality or 
cardiovascular events [64].  It is typically the presence of underlying comorbid heart 
diseases that present risk factors for mortality regardless of whether the patient has 
syncope or not.  The major focus of the evaluation of patients with syncope should 
therefore be to identify and treat underlying heart disease, since it is this that 
determines prognosis.  Patients with cardiac causes are reported to have a one-year 
mortality of 18%-33%, as compared to 6%-12% in patients with syncope of non-
cardiac or unknown origin [36, 63, 65-68].  In some studies arrhythmic syncope 
accounted for up to 70% of all cardiac causes, with an incidence of sudden death at 
30% over 5 years in the cardiac groups of patients.  Decreased left ventricular 
function, coronary artery disease and outflow obstruction has been correlated to this 
increased risk of mortality. The absence of heart disease therefore appears to be a 
marker of better prognosis. Ventricular arrhythmias and in particular inducible 
monomorphic ventricular tachycardia during electrophysiological studies appearing 
on a substrate of previous myocardial ischemia [69-71] have been suspected to be 
associated with a poor prognosis. Ventricular tachycardia, which is classically feared 
in arrhythmogenic syncope, is however much less frequent than presumed.  One study 
reported the incidence of acute cardiac ischemia among patients with syncope at 
around 7% [72].  
 
Sudden cardiac death is an important reported cause of mortality in adults in 
industrialized countries [73] and some studies suggest that syncope can be a predictor 
of sudden death.  Certain specific cardiac causes of recurrent syncope do indeed 
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sometimes initially present through episodes of syncope but in the literature they 
constitute a small fraction of all causes [74].  The incidence of sudden death is 
reported to be ~24% in patients with a cardiovascular cause as compared to ~4% in 
patients with a non- cardiovascular cause and 3% of in syncope of unknown cause.  It 
is interesting to note that Hippocrates, more than 2,400 years ago (approximately 400 
BC), described situations in which “those who are subject to frequent and severe 
fainting attacks without obvious cause die suddenly”.   
 
Arrhythmic syncope can often lead through a common pathway to an arrhythmic 
death.  These include conditions such as congenital long QT syndrome, Wolff-
Parkinson-White syndrome, Brugada syndrome, hypertrophic cardiomyopathy, 
congenital artery syndromes, arrhythmogenic right ventricular dysplasia, idiopathic 
restrictive and dilated cardiomyopathy, and Stokes-Adams attacks with 
atrioventricular block and/or transient asystole [14] can all cause syncope and 
predispose to sudden death through arrhythmias, often ventricular fibrillation [75].   
 
Symptoms, although essential in the diagnostic workup and in assigning non-cardiac 
causes as an aetiology, do not appear to help in risk-stratifying patients whose cause 
of syncope remains of unknown origin after an initial history and physical exam.  A 
prospective study of 497 patients evaluating this precise question [76] concluded that 
triage decisions and management plans should be based on pre-existing cardiac 
disease or electrocardiographic abnormalities 
 
A retrospective study [77] of 210 patients presenting to a British accident and 
emergency department with syncope proposed that stratification of patients according 
to prognostic indicators using American College of Physicians guidelines as opposed 
to stratification according to diagnosis, allowed a more efficient and apparently safer 
workup, including helping physicians to decide whether or not to hospitalize patients, 
the aim being to identify high risk individuals (those with underlying heat disease).  
The article concludes that management decisions are more important than diagnoses, 
and that physicians should assign a prognosis rather than a diagnosis and make 
decisions accordingly 
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Age has an important impact on prognosis, especially where elderly patients have a 
poorer prognosis independent of the diagnostic category, as opposed to younger 
patients in whom prognosis is intimately dependant on the underlying cause, in 
particular with an increase in sudden death where cardiovascular causes are present 
[44]. 
 
The usefulness of specific diagnostic tests in identifying clinical entities causing 
syncope was increasingly reported during the 1980’s.  Studies evaluating prolonged 
electrocardiographic monitoring (Holter) showed for example, that it is rarely helpful 
in assigning causation of syncope.  However non-diagnostic abnormalities emerged 
and these increased the likelihood of patients going through further electrophysiologic 
testing [78-80].  Studies of electrophysiological testing have raised a number of 
limitations linked to the lack of sensitivity and specificity for diagnosing 
bradyaryhthmias and polymorphic ventricular tachycardia. Certain facts emerged 
nonetheless, showing that these tests were rarely abnormal in patients with normal 
heart and electrocardiogram, whereas a left ventricular ejection fraction < 40%, left 
bundle branch block and a history of coronary artery disease were predictors of 
positive electrophysiologic studies [81-89].  
 
The use of basic laboratory tests, computed tomography scans, non invasive carotid 
studies and electroencephalography and stress tests rarely established a diagnosis [1, 
35, 38], and were only recommended after careful history-taking and physical 
examination when clinical presentation was highly suggestive of the entities being 
considered. 
 
Tilt table testing has been widely used in the evaluation of neurally-mediated syncope 
in patients with unexplained syncope after extensive and negative workup [90]; a 
diagnosis specificity of more than 90%  was established in one study of 505 patients. 
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A risk classification system for patients presenting to emergency departments with 
syncope was evaluated in two prospective studies [91].  A cohort of 252 patients was 
followed in one group to develop the classification; a second group of 374 patients 
was used to validate the system.  The key determinants for the stratification of 
patients’ risk of arrhythmias and mortality within one year of presenting to the 
emergency department were history and electrocardiographic findings at the time of 
presentation. 
 
However, despite extensive investigations, the recurrence rate of syncope appears 
high, in particular in cases of cardiac and vasovagal syncope.  Furthermore, syncope 
of certain specific cardiac origins is genuinely a predictor of sudden death and overall 
mortality, and these causes must therefore be searched for in specific groups of 
patients.   
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4.0 Investigation 
 
4.1 Introduction 
 
 
Numerous reviews have summarized syncope-related work-up strategies [35, 43, 53, 
92-96].  Studies done at the beginning of the 1980’s [63, 65, 97] found that anywhere 
between 5-47% of syncope cases were classified with an “unknown origin” despite 
extensive work-ups.  Notably a prospective evaluation in 1983 [63] of 204 patients 
assigned a cause in only approximately 50% of cases (107 patients; 53 cardiovascular, 
54 noncardiovascular) leaving 97 patients with syncope of unknown origin.  Overall 
mortality was ~14%, with mortality however, significantly higher in the patients with 
a cardiovascular cause at ~30% as compared to ~12% in the noncardiovascular group 
and ~6% in the group with syncope of unknown origin. 
 
Several studies have reviewed the value of clinical histories, physical examination, 
selected diagnostic tests and their capacity in identifying high-risk subgroups of 
patients with poor prognosis.  These studies remain inconclusive, however, in part 
because the sample populations have often been biased, and for example have at times 
involved patients who had been referred to specialized clinics.  Furthermore, the yield 
of different tests has been relatively disparate.  For example the range for the yield of 
history-taking and physical examination in identifying the cause of syncope is 32%-
75% [36, 65-67].  The reason for this variability is in part, the fact that the populations 
being studied were highly heterogeneous, varying from emergency room to intensive 
care unit patients and from primary care centre to referral tertiary care hospitals.   
 
The diagnostic usefulness of clinical histories in identifying causes of syncope has 
also been poorly reviewed, and because the cost of evaluations is increasing 
dramatically, it is generally accepted that risk-stratifying strategies must be developed 
so that patients can be identified quickly in terms of those who are likely to benefit 
from workups and those who are less likely to.  This lack of a rational and cost-
effective diagnostic approach to evaluating patients presenting in primary care centres 
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with syncope can mean that a large proportion of these patients continue to undergo 
excessive diagnostic testing whose proven clinical benefits. 
 
The recommended assessment of patients presenting with syncope includes taking an 
initial history and physical examination, a 12 lead ECG, search for orthostatic 
hypotension and testing for carotid hypersensitivity, where the findings should guide 
further non-invasive or invasive testing.  In patients with syncope of undetermined 
origin, those with established structural heart disease should be tested for arrhythmias, 
but with an unknown sequence of exams; those with negative findings might require 
tilt testing.  In patients without clinical evidence of structural heart disease, the  
likelihood of arrhythmias is very low [35, 65] and therefore the need for prolonged 
electrocardiography monitoring is questionable.  In patients without clinically evident 
heart disease, but “possible” underlying heart condition, the role of cardiac evaluation 
such as echocardiography is unknown.  In all age groups, vasovagal and psychiatric 
disorders should be considered, but whether upright testing and psychiatric 
assessment should be systematically performed is also unknown. 
 
 
4.2 Aim of the investigation 
 
 
It is in this context that this study was conceptualised and conducted.  The study was a 
prospective evaluation of patients with syncope, and was designed to determine the 
diagnostic yield of a standardized sequential evaluation of patients with syncope in a 
primary care teaching hospital, representing a community-based sample of patients. 
 
A secondary aim of the research was to describe the spectrum of clinical entities 
causing syncope in an unselected population of patients presenting to the emergency 
department of a primary care centre.  Most clinical studies describing the underlying 
causes of syncope were performed prior to 1980 or in the 1980’s, well before the era 
of coronary artery reperfusion procedures and systematic secondary prevention after 
myocardial infarction (for example antithrombotic and beta-blocker therapy).  This 
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means that the current etiological spectrum may be different, and that the prevalence 
of arrhythmias is possibly lower than suggested by earlier studies. 
 
Another aim of the study was to assess the diagnostic yield of the history, clinical 
examination and specific diagnostic examinations (baseline ECG, 24-hour Holter 
monitoring, signal-averaged electrocardiography loop recorder, echocardiography and 
upright tilt testing) using established diagnostic criteria (see annexe) as a measure of 
their performance.   
 
This workup represented the initial recommended assessment.  The study also set out 
to assess rates of recurrence of syncope, cardiovascular events and mortality. The 
specific yield of the clinical history and physical examination in assessing the risk of 
syncope of cardiac origin together with the predictive values of complementary 
diagnostic tests was also tentatively assessed. 
 
It was understood that when investigating a “symptom” such as syncope, surrogate 
endpoints needed to be used to accommodate the lack of a diagnostic “gold standard”.  
No specific diagnostic test can be considered to either objectively confirm the 
“syncopal” event or establish its cause. Because of this lack of a gold standard, 
sensitivity and specificity for specific evaluation components and tests cannot be 
determined, and therefore the notion of a diagnostic yield was evaluated.  The 
diagnostic yield represented the number of patients with a positive diagnostic test 
result divided by the number of tested patients. The use of a two-year observational 
follow up of patients with a final established diagnosis based on strict criteria also 
served as a substitute for such a gold standard in assigning a diagnosis. 
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4.3 Methods 
 
4.3.1 Study setting and design 
 
 
Patients aged 18 years or older, presenting to the emergency department and the 
inpatient services of the Hôpital Cantonal of the University of Geneva, with a chief 
complaint of syncope in the study period between July 1, 1997, and March 31, 1999, 
were prospectively enrolled, after obtaining their informed written consent.  The 
patients were identified on a daily basis through the admissions records file and 
through regular visits to emergency and internal medicine interns.  Syncope was 
distinguished from other entities, in particular those not characterized by a loss of 
consciousness, those without spontaneous recovery and from generalized tonic clonic 
seizures, which all enter another differential diagnosis and necessitate specific 
workups. 
 
A standardized evaluation (see table 2) was performed in the emergency department 
on all patients.  This included a complete history (age, gender, number of previous 
episode of syncope, presence or absence of premonitory signs or symptoms), physical 
and neurological examination, a laboratory workup (hematocrit, serum levels for 
creatinine kinase and glucose), a 12-lead electrocardiogram, testing for orthostatic 
hypotension and bilateral carotid massage in patients without contraindications. 
Baseline data from the clinical history, physical examination, current medications, 
cardiovascular risk factors, the Charlson Co-morbidity Index score [98] conditions 
and results of all tests were collected daily using a standardized evaluation and follow 
up form (see appendix 7.4). The protocol also provided specific diagnostic criteria for 
the disease categories, collecting information on seizures, stroke or transient ischemic 
attacks, aortic stenosis and pulmonary embolism as well as serving as a reminder of 
these criteria; questioning of witnesses was done whenever possible. 
 
This initial and preliminary evaluation enabled patients to be classified into three 
groups: (a) patients in whom the aetiology of the syncopal episode was strongly 
suspected; (b) those in which an aetiology was suspected based on suggestive 
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symptoms or signs, requiring confirmation by selected diagnostic exams; and (c) 
those in whom the cause of syncope remained undetermined (see figure 2).  
 
The latter category of patients underwent further and more extensive cardiovascular 
testing including prolonged electrocardiographic monitoring using 24–hour Holter 
and continuous-loop event recorders, transthoracic echocardiography, signal average 
electrocardiography and upright passive tilt table testing.   
 
Electrophysiological testing was carried out selectively in patients with structural 
heart disease and electrocardiographic abnormalities detected during prolonged 
monitoring or with late potentials in the signal average electrocardiogram, as 
recommended in the literature guidelines.  Initial diagnoses were based on disease 
specific diagnostic literature based definitions and criteria (see appendix 7.1 and 7.2) 
and confirmation of diagnosis was based on the prospective and observational study 
follow up as well as strict adherence to these diagnostic criteria. 
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Figure 2 Flow diagram of the study design 
After an initial evaluation patients were categorized into three groups, 
conditioning further examinations 
 
 
 
Initial 
assessment 
Strongly suspected 
diagnosis 
Table 2 Initial evaluation and complementary exams 
 
 
The initial workup comprised: - a complete history 
- a physical and neurological examination 
- a succinct laboratory workup 
  (hematocrit, creatinine kinase and glucose) 
- a 12-lead electrocardiogram 
- testing for orthostatic hypotension 
- bilateral carotid massage 
  (in patients without contraindications) 
 
Complementary exams included: - prolonged electrocardiographic monitoring: 
- 24 –hour Holter 
- continuous-loop event recorders 
- transthoracic echocardiography 
- signal average electrocardiography 
- upright passive tilt table testing 
- electrophysiological testing in selected patients 
 
Suspected 
diagnosis 
Undetermined 
cause of syncope 
Cease further 
testing 
Selected tests 
Further 
cardiovascular 
testing 
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4.3.2 Diagnostic criteria 
 
Each patient case of syncope was discussed by a committee of two internists (Dr 
Francois Sarasin and Dr Martine Louis-Simonet, Internal Medicine department, 
HUG) and a cardiologist (Dr Jacques Metzger, Cardiology department, HUG), in 
order attribute a final diagnosis.  This was done using explicit and reproducible 
criteria that are summarized in the annex.  In certain specific cases when the 
relationship between the syncopal episode and clinical findings was indispensable to 
assigning a diagnosis, as with certain cases of orthostatic hypotension or neurally 
mediated syncope during tilt testing, reproduction of syncopal or presyncopal 
symptoms was required to formally attribute a diagnosis. 
 
 
4.3.3 Follow up 
 
 
The prospective evaluation was an observational study, with an 18 months inclusion 
period, followed by an 18 months follow-up period after enrolment, during which 
syncope recurrence and mortality data was obtained from primary care physicians and 
through telephonic contact with the patients or their relatives at 6 months intervals. 
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5.0 Results 
 
During the enrolment period, 788 (1.1%) of the 67,837 patients admitted to the 
emergency department presented with a chief complaint of syncope. Of these, 650 
patients (82%) were included in the study; 115 did not complete the initial 
standardized evaluation and 23 patients refused to participate (see table 3). 
 
The evaluation protocol, the classification of patients in three presumed diagnostic 
groups and the complementary exams determined an overall etiological spectrum,    
89 % (581 patients) of overall cases being attributed to non cardiac and 11% (69) to 
cardiac causes (see tables 4, 8 and 9) [3]. 
 
The initial testing strategy allowed an etiology to be strongly suspected and therefore 
assigned in 446 patients (69%) and suspected in a further 67 patients (10%), requiring 
further targeted diagnostic testing, being confirmed in 49 (73%) of them (see figure 
3).  The detailed history and clinical examination led to a diagnosis in 245 patients 
(38%), with neurocardiogenic causes, including vasovagal (212 patients) and 
situational disorders (22 patients), representing the largest diagnostic subgroup with 
53 % of cases (234 patients) (see table 5).  The characteristics of this latter group, 
diagnosed in the emergency room, show a generally younger group of individuals, 
with fewer comorbid cardiovascular diseases.  Systematic and standardized 
measurements of orthostatic hypotension was performed in 611 (94%) of patients, and 
allowed an orthostatic causes to be attributed in 156 (24%) patients [4], with a further 
subdivision related to concomitant details; 59 (38%) of these presented with drug-
related hypotension (80% with angiotensin-converting enzyme (ACE) inhibitors), 34 
(22%) were diagnosed with hypovolemia, 19 (12%) had postprandial hypotension and 
44 (28%) had idiopathic hypotension. 
 
The 12-lead electrocardiogram was able to strongly suggest a cause in 33 (5%) of the 
patients; 24 of them had documented arrhythmias and 9 presented with acute coronary 
syndromes.  The overall proportion of patients with arrhythmias was nevertheless 
relatively low. 
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Table 3 Inclusion rate 
 
 
 
Data 
 
Number (%) 
 
Syncope as a chief complaint 
 
788/67,837 (1.1%) 
 
Enrolment 
 
650/788 (82%) 
 
 
 
 
 
 
Table 4 Epidemiological characteristics of the 650 included patients with 
syncope 
 
 
 
Characteristics 
 
Number (%) 
 
Age (years) 
 
60 ± 32  
Age range (years) 18-93 
Number ≤ 65 years old 341 (52) 
Male sex 310 (48) 
Previous syncopal episode  
                None 362 (56) 
                One 143 (22) 
                Two or more 145 (22) 
                Last episode in preceding year 130 (20) 
Comorbid conditions  
                Coronary artery disease 104 (16) 
                Previous myocardial infarction 57 (9) 
                Heart failure 61 (9) 
                Hypertension 229 (3) 
                Diabetes Mellitus 54 (8) 
                Peripheral vascular disease 57 (9) 
                Chronic obstructive pulmonary disease 26 (4) 
Charlson Comorbidity Index score  
                O 417 (64) 
                1 or 2 184 (28) 
                3 or 4 36 (6) 
                5 or more 
 
13 (2) 
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Figure 3 Diagnostic yields after initial evaluation phase of the 650 patients 
 
 
 
 
Enrollment (n=650) 
 
Initial assessment 
- history 
- physical examination 
- testing for hypotension 
- 12-lead ECG 
- carotid sinus massage 
Strongly suspected 
(probable) cause of 
syncope (n=446) 69% 
Suspected diagnosis 
(n=67) 10% 
Probable cause of 
syncope confirmed by 
selected tests 
(n=49) 7% Undetermined cause of 
syncope (n=155) 24% 
Possible diagnosis 
refuted by selected 
test (n=18) 3% 
Further cardiovascular 
testing 
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Table 5 Etiological spectrum of syncope after the initial non invasive 
evaluation in 446 patients in whom a diagnosis was assigned 
 
 
 
 
Etiology of syncope 
 
Number of patients (%) 
 
Noncardiac causes  
                vasovagal 212 (48) 
                situational 22 (5) 
                hypotension 156 (35) 
                      idiopathic 44 (10) 
                      drug related 59 (13) 
                      hypovolemia-related 34 (8) 
                      post-prandial 19 (4) 
                carotid sinus hypersensitivity 4 (1) 
Cardiac causes  
Arrythmia 24 (5) 
                atrioventricular block 8 
                sinus bradycardia or pause 8 
                supraventricular tachycardia 4 
                ventricular tachycardia 3 
                pacemaker malfunction 1 
Acute coronary syndrome 9 (2) 
Psychiatric 11 (2) 
Others 8 (2) 
                hypoglycemia 3 
                gastrointestinal hemorrhage 2 
                sub-archnoid hemorrhage 1 
                subdural hematoma 1 
                intracranial hemorrage 1 
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.Carotid sinus massage was performed in 432 (67%) patients.  It was abnormal in 16 
patients, but considered diagnostic in only 4 (0.5%) of them.  Laboratory exams 
identified anemia with subsequent gastrointestinal hemorrhage being confirmed in 2 
patients and hypoglycemia in 3 patients. 
 
A specific cause of syncope was thus able to be attributed to 446 patients (see tables 5 
and 6) after the initial evaluation, and a further 49 after selected testing (see table 7), 
leaving 155 (24%) with an undetermined cause.  Extensive cardiovascular testing in a 
further 122 of these patients enabled a diagnosis to be assigned found in another 30 
(25%) of these. Although beyond the scope of this thesis, the specific diagnostic yield 
of Holter monitoring, ambulatory loop recorder, echocardiographic examination, 
upright tilt testing, late potentials on signal averaged electrocardiogram and 
electrophysiological studies (in selected patients) were also independently evaluated 
[5, 6].  Results showed that the yield of these examinations was proportional to the 
pretest probability and the presence or not of a positive history and abnormal baseline 
12-lead electrocardiogram.  In particular, the echocardiographic examination, 
performed in 122 patients, did not reveal any unexpected cardiac abnormalities. 
Furthermore, the yield of prolonged electrocardiographic monitoring was only 10% 
amongst non selected patients, but increased to 19% when applied to patients with an 
abnormal baseline electrocardiogram. 
 
Cardiac causes and orthostatic hypotension were more prevalent in the elderly 
population. The mean age of patients with a cardiac cause was 74 years, with 61% of 
all cardiac causes being determined in patients over the age of 75 years; the mean age 
of patients with orthostatic hypotension was 63 years 
 
Follow-up data was collected in 611 (94%) patients at 18-months, with a 9% (55 
patients) mortality rate, 8 of which were attributed to sudden death (see table 8).  The 
data also showed that 15% (95) of patients presented at least one episode of 
recurrence of syncope, and 8% (37 patients) two or more. Of note, 60% (57) of them 
recurred within one year.  The recurrence rates for patients with vasovagal syncope 
was 17% (41 of 242), 15 % (24 of 158) for patients with hypotension, 15 % (14 of 92) 
with unexplained syncope and 9% (6 of 69) of patients with a cardiac cause to their 
syncope.
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Table 6 Diagnostic yield of initial evaluation 446 patients 
 
 
 
Examination 
Yield 
Number of patients (%) 
 
History & physical examination 
 
245 (38) 
 
Testing for hypotension 
 
156 (24) 
 
12-lead electrocardiogram 
 
33 (5) 
 
Carotid sinus massage 
 
 
4 (0.5) 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7 Etiological spectrum of syncope after the initial non invasive 
evaluation in 67 patients in whom a diagnosis was suspected 
 
 
 
Suspected cause 
 
Number (%) 
 
Confirmed (%) 
 
Seizures 
 
31 
 
22 (71) 
Stroke/ transient ischemic attack 11 8 (73) 
Pulmonary embolism 11 8 (73) 
Aortic stenosis 10 8 (80) 
Others 4 3 (75) 
              arrhythmia 2 2 
              mastocytosis 1 1 
              subdural hematoma 1 0 
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Table 8 Overall etiological spectrum and mortality of syncope 
in the 650 patients 
 
 
 
Etiology of syncope 
 
Number 
(%) 
 
18-month 
Mortality 
Number 
(% of category) 
Sudden death
Number 
(% of 
category) 
    
Cardiac 69 (11) 18 (26) 5 (7) 
    Arrythmias 
        - Sinus bradycardia or pause 
       - Atrioventricular block 
       - Ventricular tachycardia 
       - Supraventricular tachycardia 
        -Pacemaker malfunction 
    Acute coronary syndromes 
    Aortic stenosis 
    Pulmonary embolism 
44 (7) 
15 
15 
9 
4 
1 
9 
8 
8 
 
Noncardiac causes 456 (70) 28 (6) 3 (0.7) 
    Vasodepressor syncope 
    Orthostatic hypotension 
    Carotid sinus hypersensitivity 
    Neurologic 
    Psychiatric 
    Other 
242 (37) 
158 (24) 
6 (1) 
30 (5) 
11 (1.7) 
9 (1.4) 
 
Unknown 92 (14) 6 (7) 0 
Incomplete evaluation 33 (5)  0 
 
Other includes: Hypoglycemia (n=3), gastrointestinal hemorrhage (n=2), subarachnoid 
hemorrhage (n=1), subdural hematoma (n=1), intracranial hemorrhage (n=1) and systemica 
mastocytosis (n=1) 
 
 
 
 
 
Table 9 Cardiac versus noncardiac causes of syncope 
 
 
Cardiac 
Number (%) 
Non cardiac or unknown 
Number (%) 
 
69 (11) 
 
 
581 (89) 
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6.0 Discussion 
 
 
Interest in syncope continues to grow.  The need for efficiency in its timely diagnosis 
is predicated on a number of conditions.  The first and most important is the need to 
provide the type of assessments that permit patients to be treated in ways that are most 
appropriate to their condition and the risk(s) they may be exposed to as a result of that 
condition.  The second is the growing reality that as the technology of diagnosis 
becomes more sophisticated so do the economic and psychosocial costs associated 
with workups and hospitalization.  Improving our understanding of syncope and 
translating that knowledge into operational guidelines and methods can begin to 
satisfy both those pressing requirements. 
 
This prospective observational study demonstrated that up to 70% of patients 
presenting to a primary care emergency room with syncope could have a likely cause 
of syncope ascribed without the use of extensive complementary exams. That is to say 
that additional examination and assessment might only be necessary for 30% of 
patients presenting with the condition, a vast saving in time, economic costs to the 
system and psychological and social costs to the patient and his/her family.   
 
The study demonstrated that the value of the initial history and physical examination 
are the most important actions and that they provide the highest yield.  Systematic 
searches for orthostatic hypotension showed the second highest yield.  Using a 
standardized protocol focusing on these aspects as well as acting as a reminder of 
specific disease diagnostic criteria and a rigorous application of these criteria appears 
key to a cost-effective workup of syncope and decreases the number of patients with 
syncope of undetermined origin. Secondly, targeted testing was also shown to be an 
effective way of assigning an etiology in up to 7% more patients, thus avoiding costly 
and probably unnecessary further cardiovascular testing.  
 
The value of further cardiovascular testing in patients whose cause of syncope 
remained undetermined after the initial workup greatly depended on the history and 
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baseline 12-lead electrocardiogram. Overall mortality and in particular sudden death 
was highest amongst patients to whom a cardiac cause attributes, confirming previous 
data available. The recurrence rate at 15% also coincides with statistics previously 
published. 
 
As was postulated, the established etiological spectrum differed from other 
population-based studies, with a higher proportion of neurocardiogenic causes, be it 
vasovagal or situational. This is possibly due to the fact that the standardized protocol 
searched for specific symptom elements and precipitating factors in the history and 
conveyed the criteria on which the diagnosis could be established, avoiding areas of 
possible doubt or subjective interpretation. Considering the fact that during the 18-
month follow-up period, the incidence of sudden death was extremely low in this 
group of patients, it seems unlikely that syncope of cardiac origin was mistakenly 
considered as a neurocardiogenic disorder. 
 
The high occurrence of orthostatic hypotension can possible attributed to the 
increased use of anti-hypertensive drugs in this era of ever more rigorous guidelines 
on the treatment of hypertension and the concomitant higher use of these drugs in post 
myocardial secondary prevention. Of particular note is the increased use of 
angiotensin converting enzyme inhibitors. Also, the high prevalence of post prandial 
hypotension in the elderly population accounts for a significant number of cases. 
 
Finally, the study was conducted in an era of regular revascularization in patients with 
coronary artery disease and presenting with acute coronary syndromes. This, 
associated with secondary cardiovascular prevention, might explain the lower the 
previously published proportion of patients with cardiac arrhythmias as an established 
cause of syncope. 
 
Although beyond the scope of this thesis, it is relevant to underline that baseline 
history and 12-lead electrocardiographic abnormalities, significantly determined the 
relative diagnostic yield of further cardiovascular testing, emphasizing the importance 
of such stratification. Be it prolonged electrocardiographic monitoring, 
echocardiography or passive tilt table testing, the yield was overall low in the 
category of patients with unexplained syncope. Specifically, baseline 
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electrocardiographic abnormalities, irrespective of underlying heart disease appeared 
as a primary determinant of the yield. 
 
A left ventricular ejection fraction of less than 40% was systematically correlated with 
a history of heart disease and an abnormal electrocardiogram. The determination of 
the ejection fraction emerged however, both in this study and others, as fairly 
important to in estimating the prognosis of more than in establishing the etiology of 
syncopal episode. 
 
As indicated in the introduction, the lack of a gold standard against which to compare 
the diagnostic value of individual elements in this standardized evaluation means that 
the strict correlation between examination results an the assigned etiology remains 
somewhat uncertain, despite the use of strict diagnostic criteria in attributing the 
diagnosis. The follow-up period probably partially counterbalances this study 
limitation. Other limitations to this study include a recently established fact, which is 
the higher than previously thought prevalence of psychiatric conditions leading to 
syncope. The lack of a systematic and standardized instrument for detecting these 
disorders means that a certain number of such entities were potentially under 
diagnosed. 
 
As medicine moves forward and attempts to address the needs of a population whose 
demographic and behavioral characteristics may be placing it at ever-growing risk of 
syncope and of cardiovascular disease, the need for evidence-based diagnostic 
procedures is becoming not only more evident but more fundamentally essential.  
Syncope is a widely occurring phenomenon affecting different age groups, but older 
ones more than others.  For all age groups the availability of rapid diagnostic 
guidelines based on the type of findings this study generated could make a major 
difference in the way in which their health and welfare is managed in emergency 
room settings where most syncope patients present. 
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7.0 Appendix 
 
7.1 Diagnostic criteria for non cardiac causes [63, 66, 67, 99] 
 
Vasodepressor or vasovagal syncope (neurocardiogenic) [67, 91] 
Vasodepressor syncope was diagnosed if a precipitating event such as fear, severe 
pain, minor injury or instrumentation was identified, in the presence of premonitory 
vasovagal symptoms such as nausea, diaphoresis, fatigue or dizziness.  
 
For patients falling into the unexplained syncope category, upright tilt testing was 
used to attribute the diagnosis as described under the criteria for tilt table testing. 
 
Neurocardiogenic syncope was further subdived into situational syncope with the 
following definitions 
 
Cough syncope was invoked as the cause of syncope when a loss of consciousness 
occurred immediately following a paroxysm of sever cough with no other apparent 
cause for syncope. 
Micturition syncope was defined as syncope occurring at the beginning, during, or 
immediately at the termination of urination, with no other apparent cause for the 
episode. 
Defecation syncope was defined as syncope occurring during or immediately after 
defecation, with no other apparent cause for the episode 
 
Orthostatic hypotension 
Orthostatic hypotension was implicated as the cause of syncope if there was a 
decrease of the systolic blood pressure of more than 25 mmHg associated with 
dizziness or syncope on repeated orthostatic blood pressure determination over a 10 
minute period following baseline values after 5 minutes in the supine position. An 
orthostatic systolic decrease of 10 to 25 mmHg, when associated with a systolic blood 
pressure decreases too less than 90 mmHg upon standing with or without symptoms, 
was also considered as a probable cause. Further categorisation was made based on 
the concomitant intake of hypotensive drugs, hypovolemia or postprandial 
circumstances 
 
Seizure disorder, transient ischemic attacks (TAI) and psychiatric disorders 
To implicate a seizure disorder as the cause of syncope, the patient had to either have 
had a witnessed episode of tonic-clonic movements of prolonged duration, 
unconsciousness longer than 5 minutes or a post-ictal state, with 
electroencephalographic findings used to confirm the presence of a seizure focus.  
 
TIA was defined as an episode of temporary and focal cerebral dysfunction (such as 
symptoms of vertebrobasilar ischemia, impaired sensory or motor function or 
transient amaurosis)lasting up to 24 hours followed by complete recovery. 
Confirmation by a staff neurologist was required in order to diagnose a seizure 
disorder or a TIA as the cause of loss of consciousness. 
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Psychiatric illnesses considered as potentially diagnostic were generalized panic 
disorders, panic and somatization disorders, associated or not with major depression, 
with evaluation by a staff psychiatrist [100]. 
 
Subclavian steal syndrome 
Syncope due to a subclavian steal syndrome was diagnosed when typical clinical 
manifestations were present and a subclavian steal was demonstrated by Doppler 
ultrasound or angiography 
 
7.2 Diagnostic criteria for cardiac causes [67, 99] 
 
(Also reviewed under diagnostic criteria for echocardiography) 
 
Aortic stenosis and hypertrophic cardiomyopathy [101] 
Aortic stenosis was considered the cause of syncope clinically it was suspected with 
the presence of an aortic systolic murmur and syncope with exertion and when there 
was clear-cut findings compatible with severe outflow tract obstruction on 
echocardiography or if severe outflow obstruction was documented by cardiac 
catheterisation. 
 
Pulmonary hypertension [102] 
Pulmonary hypertension was implicated as a cause of syncope if the pulmonary artery 
pressure or the mean pulmonary artery pressure exceeded 30 mmHg at rest on 
echocardiography, and if there is no other apparent cause of syncope  
 
Myocardial infraction 
Myocardial infarction was implicated only if a patient presents with syncope and has 
concurrent standard criteria for the diagnosis were present such as typical 
evolutionary ECG changes and or compatible cardiac enzyme elevations and there 
was no other documented cause such as arrhythmias 
 
Pulmonary embolism [103, 104] 
Pulmonary embolism was implicated as the cause of syncope if the clinical 
presentation was compatible and lower limb Doppler ultrasound, lung scan or 
angiography confirmed the diagnosis. 
 
Carotid sinus hypersensitivity syncope 
Carotid sinus syncope was defined as a cardiac asystole of ≥ 3 seconds and/or a 
decrease in systolic blood pressure of greater than 50 mmHg when the carotid sinus 
was stimulated for up to 5 seconds. In addition, the syncopal episode must have been 
precipitated by activities which pressed on or stretched the carotid sinus  
 
Dysrthymias 
Criteria for abnormal but non diagnostic electrocardiographic findings and for 
diagnostic electrocardiographic findings are defined under ECG anomalies. 
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7.3 Diagnostic criteria for diagnostic tests [67] 
 
Prolonged electrocardiographic monitoring was performed using 24-hour Holter and 
continuous-loop event recorders (R-Test Evolution, Novacor SA, France) 
 
ECG, Holter and loop recorder 
 
Clinical and ECG anomalies diagnostic of the origin of syncope 
 
i. Sinus pause (asystole) ≥ 3 secondes 
ii. Sinus bradycardia ≤ 35/min 
iii. Second degree atrioventricular (AV) bloc, Mobitz II° type 2  
iv. Complete atrioventricular (AV) bloc, Mobitz III° 
v. Symptomatic or sustained ventricular tachycardia (≥ 30 seconds) 
vi. Non sustained ventricular tachycardia (≤ 30 seconds) ≥ 5 seconds ≥ 100/min 
vii. Supraventricular tachycardia ≥ 30 seconds at ≥ 180/min or associated with  
systolic hypotension (≤ 90 mmHg) 
viii. Atrial fibrillation ≥ 30 seconds with a slow ventricular response or a rapid  
ventricular rate at ≥ 180/min. 
 
ECG Anomalies possibly diagnostic of syncope 
 
i. Asystole ≥ 2secondes-≤ 3 seconds with syncope or presyncope 
ii. Symtomatic sinus bradycardia between 35-40/min 
iii. Atrioventricular (AV) Bloc II° type 1 
iv. Left or right bundle branch bloc 
v. Non sustained ventricular tachycardia (≤ 30 seconds) ≥ 3 beats but ≤ 30 sec. 
vii. Supraventricular tachycardia ≤ 30 seconds 
viii. Atrial fibrillation ≤ 30 seconds 
ix. Ventricular extrasystole ≥ 10/hour 
x. ST segment elevation or decrease ≥ 1mm 
 
Electrophysiologic studies (EPS) [105-107] 
 
Electrophysiological studies were restricted to patients fulfilling literature based 
recommendations. The indications for electrophysiological testing included: 
 
1. Patients with previous myocardial infarction associated with left ventricular 
fraction ≤ 40% 
2. Late potentials on signal-averaged electrocardiogram associated with previous 
myocardial infraction or episodes of nonsustained ventricular tachycardia during 
Holter monitoring 
3. Electrocardiographic findings suggestive of sinus node dysfunction or 
atrioventricular block (such as bundle branche block (with or without axis deviation) 
with or without 1° atrioventricular block) or permanent or intermittent AV conducting 
abnormalities. 
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Abnormal EPS with diagnostic findings 
 
i. Prolonged corrected sinus node recovery time (CSNRT) > 550 milliseconds 
ii. H-V interval > 100 milliseconds 
iii. H-V with Ajmaline > 100ms or doubled or distal block 
(induced infra-Hisien block) 
iv. Sustained ventricular tachycardia (> 30 seconds) 
v. Supraventricular tachycardia or atrial fibrillation ≥ 180/min associated with 
hypotension (supine systolic blood pressure < 80mmHg) 
 
Abnormal EPS with suggestive findings  
 
i. Corrected sinus node recovery time (CSNRT) 550-600 ms 
ii. Wenckebach < 120bpm (despite 1mg Atropine) 
iii. H-V interval 55-100 ms 
iv. H-V wuth Ajmaline 55-100 ms 
v. Supraventricular tachycardia with symptoms 
 
Signal-average ECG [108, 109] 
 
Signal-averaged ECG is used to reduce random noise in electrocardiographic 
recordings and to enhance detection of low-amplitude signals in the terminal portion 
of the QRS complex. A HI-RES Module system (Marquette Inc., France) with 
bidirectional Butterworth filtering (40-250 Hz) was used in this study. 
 
Late potentials were considered present if two out of three criteria were present, 
namely: i.  Total filtered QRS vector magnitude > 117 milliseconds 
  ii.  Low amplitude signal (LAS)-40 > 38 milliseconds 
  iii.  Root –mean-square voltage (RMS) < 20 µv 
 
 
Echocardiography [110] 
 
Diagnostic echocardiography 
i. Aortic stenosis with a mean aortic gradient exceeding 50 mmHg and a valvular area 
≤ 0.9 cm2 
ii. Hypertrophic cardiomyopathy with or without outflow obstruction 
iii. Pulmonary hypertension with mean pulmonary artery pressure exceeding 
30mmHg 
iv. Left atrial myxoma or thrombus with mitral protrusion and outflow obstruction 
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Abnormal echocardiography (structural heart disease) 
i. Aortic stenosis with a gradient > 20mmHg and < 50mmHg 
ii. Moderate or severe aortic insufficiency 
iii. Mitral stenosis (valvular area < 2 cm2) 
iv. Diffuse or localized left (right) ventricular hypokinesia 
v. Left ventricular dilatation or hypertrophy (left ventricle diastolic Ø >56 mm, left 
ventricle systolic Ø > 400mm, left atrial Ø > 40 mm, septum Ø > 11 mm) 
vi. Left ventricular ejection fraction < 55% 
vii. Pulmonary hypertension with a mean pulmonary artery pressure > 20 mmHg and 
< 30 mmHg 
viii. Interatrial septal defect, septum aneurysm, thrombus, tumor 
 
Non significant abnormalities 
i. Aortic sclerosis 
ii. Aortic stenosis with a mean aortic gradient < 20 mmHg 
iii. Moderate aortic, mitral or pulmonary insufficiency 
iv. Moderate enlargement of left atrium 
 
Upright tilt testing [111, 112] 
 
Protocol During the passive upright-tilt testing protocol on a foot-plate motorized 
table, blood pressure was monitored using cuff blood pressure measurements at 1 
minute intervals with continuous electrocardiographic tracings. After measurements 
of the supine baseline blood pressure and heat rate, patients were suddenly brought to 
an upright position, at an angle of 60 degrees for a duration of 45 minutes. The end 
points of a positive tilt test were the development of syncope or presyncope in 
association with hypotension or bradycardia (or both). 
 
Three principal response patterns during head-upright tilt-table testing have been 
described, based on hemodynamic and heart rate responses: 
 
1. Type I (mixed). Initial increase in heart rate during tilt that later decreases but 
remains greater than 40 bpm or is less than 40 bpm only briefly (< 10 seconds) and 
without asystole. Asystolic period > 3 seconds. There may be an initial increase in 
blood pressure, which then decreases before heart rate decreases. 
2. Type IIA (cardioinhibitory). Initial increase in heart rate during tilt, which then 
decreases to < 40 bpm for > 10 seconds or has asystole for > 3 seconds. There may be 
an initial increase in blood pressure, which then decreases before the heart rate 
decreases. 
3. Type IIB (cardioinhibitory). Initial increase in heart rate followed by a decrese tp < 
40 bpm for > 10 seconds, or has asystole > 3 seconds. Hypotension occurs only at or 
after the time at which the heart rate decreases. 
4. Type III (pure vasodepressor). Initial increases in heart rate, which  decreases less 
than 10% from the peak value at the time of syncope. Hypotension alone accounts for 
syncope. 
 
 44
CHAPTER 7  APPENDIX 
 
 
7.4 Standardized form 
 
 
Bilan Initial 
 
Rappel: syncope=perte soudaine de connaissance transitoire avec perte de 
contrôle postural et récupération spontanée ne nécessitant pas de 
cardioversion électrique ou chimique. 
 
A. Antécédents Personnels  
 
 Cardiaque: 1- Maladie coronarienne connue: oui     non    
   2- Infarctus ancien:   oui     non    
   3- Insuff. cardiaque clinique:  oui     non    
   4- Autre cardiopathie connue: oui     non    
     Si oui:  5- valvulaire oui    non    
       6- dilatée oui    non    
       7- autre oui    non    
 
 FRCV: 8- HTA:    oui     non    
   9- Diabète:    oui     non    
   10- Hyperlipémie:   oui     non    
   11- infarctus < 50 ans c/o proche: oui     non    
   12- Tabagisme actif:   oui     non    
 
 Comorbidités connues à l’entrée (selon Charlson): 
  13- Maladie vasculaire périphérique  oui     non    
  14- AVC avec séquelle (hémiplégie)  oui     non    
  15- AVC sans séquelle   oui     non    
  16- Démence     oui     non    
  17- Diabète avec atteinte d’organe  oui     non    
  18- COPD     oui     non    
  19- Insuffisance hépatocellulaire  oui     non    
  20- Insuffisance rénale sévère  oui     non    
  21- Néoplasie, lymphome   oui     non    
  22- Métastases    oui     non    
  23- SIDA     oui     non    
  24- Collagénose    oui     non    
  25- Maladie ulcéreuse gastroduodénale oui     non    
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B. Anamnèse Actuelle et Examen Physique 
 
  1) Eléments relatifs à une cardiopathie concomitante 
 
 26- Angor ? :  1.- non   27- Dyspnée ? : 1.- non  
   2.- d’effort    2.- d’effort grade I/II 
   3.- de repos    3.- d’effort grade III/IV 
 28- Episode de dyspnée paroxystique  oui     non    
 29- Oedèmes des MI (anamn. ou clinique)  oui     non    
 30- HTA actuelle (>160/100 mmHg)   oui     non    
 31- Présence d’un B3 (galop)    oui     non    
 32- Râles de stase     oui     non    
 33- Signes d’IC droite     oui     non    
 34- Cardiomégalie radiologique   oui     non    ?   
 
  2) Eléments anamnestiques relatifs à l’épisode syncopal 
 
 35- Episode syncopal ? 1.- 1 er  36- Si pas le premier,  
      2.- 2 ème        dernier épisode < 1 an ? : 
      3.- 3 ème ou plus       oui     non    
 
 
Signes et symptômes avant et après la syncope ?:  oui     non    
 
 Si oui,?: 
37- Durée des signes prémonitoires ?:  1.- < 5 secondes 
       (avant la syncope)     2.- > 5 secondes 
        3.- non précisable 
 
       Avant   Après 
 38- nausée:                 
 39- vomissements:                
 40- chaleur:                 
 41- sudations abondantes:               
 42- tête vide:                 
 43- palpitations:                
 44- vision trouble:                
 45- fatigue:                 
 46- Autre élément anamnestique 
      relatif à la syncope:        ....................      ..................... 
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 47- Facteur ayant précipité la syncope Oui  Commentaires: 
 
  a) Blessure/injection/instrumentation:    .......................... 
  b) Douleur intense:       .......................... 
  c) Emotion / choc émotionnel:     .......................... 
  d) Angoisse / peur:       .......................... 
  e)  Repas copieux:       .......................... 
  f)  Fatigue extrême:       .......................... 
  g) Station debout prolongée:      .......................... 
  h) Chaleur (bain / douche chaude,     .......................... 
      soleil, pièce bondée): 
  i)  Manoeuvre de type Valsalva     .......................... 
      (eg. Soulevé poids, trompette): 
 
  Î Syncope vasovagale (si un des facteurs sous 47 = positif) 
 
  CAVE:  La seule existence de symptomes neurovégétatifs ne  
     Pose pas le diagnostic de syncope d'origine vasovagale. 
  
 
 
 48- Syncope après toux paroxystique   oui     non    
 49- Syncope pdt ou après miction   oui     non    
 50- Syncope pdt ou après défécation/déglutition oui     non    
  Î Syncope situationelle (48, 49 ou 50 = positif) 
 
 
 Présence d’un signe clinique évocateur d’une crise épileptique: 
 
 51- Témoignage de mouvements tonico-cloniques oui     non    
 52- Témoignage d’un état post-critique  oui     non    
 53- Cyanose faciale     oui     non    
 54- Morsure de langue    oui     non    
 55- Désorientation post-critique   oui     non    
 56- Perte de connaissance ≥ 5 min.   oui     non    
 
 Î Suspicion de syncope d’origine épileptique: à rechercher 
     (consultation neurol., EEG) si 51, 52, 53, 54, 55 ou 56 =positif 
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 Présence d’un déficit neurologique aigu focal 
 transitoire (<24hr) à l’anamnèse ou au status:   Aucun:    
 
 Si déficit,  57- parésie     oui    
 lequel:   58- amaurose     oui    
    59- troubles sensitifs    oui    
    60- troubles cérébelleux   oui    
    61- Autre: .......................................................... 
 
 Î Suspicion de syncope secondaire à un accident vasculaire cérébral: 
     à rechercher si présence d’un déficit neurologique aigu focal transitoire 
 
 
 62- Asymétrie de la TAH aux 2 bras ≥ 25 mmHg oui     non    
 
 Î Suspicion de syncope secondaire à un vol sous-clavier: 
      à rechercher si 62 = positif 
 
 
 63- Souffle systolique aortique   oui     non    
 64- Syncope à l’effort     oui     non    
 65- Syncope + douleur retrosternales   oui     non    
 66- Ralentissement montée carotidienne  oui     non    
 
 Î Supicion de syncope secondaire à une sténose aortique: 
      à rechercher si 63,64,65 ou 66 = positif 
 
 
 67- Suspicion HTA pulmonaire   oui     non    
       (dyspnée, syncope à l’effort, B2 claqué, choc droit) 
 
 Î Suspicion de syncope secondaire à une HTAP: 
      à rechercher si 67 = positif 
 
 
 68- Suspicion d’embolie pulmonaire   oui     non    
 Î Suspicion de syncope sur EP: 
      à rechercher (scinti, angio) si 68 = positif 
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C. Recherche d’hypotension, dysfonctions vagales, anomalies 
ECG ou labo 
 
 
 Tension artérielle (TA)   Test de Schellong 
 
Prise du pouls et de la tension artérielle 
coucher, immédiatement au lever, puis durant 
les minutes qui suivent 
 
TAH 
 
Pouls 
 
Observations
Position couchée (5-10 min): 
 
   
Position debout (sans appui) Î temps (Min):  0 
 
   
                                                                         +1
 
   
                                                                         +2
 
   
 
                                                                         +3
 
   
 
                                                                         +4
 
   
 
                                                                         +5
 
   
 
 
 
 69- Résultats:  1.- Chute de la TA syst. debout ≥ 25 mmHg avec  
           symptômes neurovégétatifs 
    2.- Chute de la TA syst.≥10 mmHg et ≤ 25 mmHg avec  
           une valeur abs. de la TA syst.≤90 mmHg 
    3.- Pas de changements tensionnels diagnostique 
 
 Î Syncope orthostatique (69.1 ou 69.2 = positif) 
 
 
 70- Prise concomitante de médicaments hypotenseurs: oui    non    
   Si oui, lesquels: ........................................................... 
      ........................................................... 
 71- Réaction de type anaphylactique:    oui    non    
 72- Hypotension artérielle documentée:   oui    non    
       (voir critères sous No.69) 
 Î Syncope médicamenteuse (si (70 ou 71) + 72 = positif) 
 
 49
CHAPTER 7  APPENDIX 
 
 
Hypersensibilité du sinus carotidien ou anomalies au Valsalva 
 
 73- Asystolie ≥ 3":     - au massage du sinus G:      oui          non    
        - au massage du sinus D:       oui          non    
        - au Valsalva:        oui          non    
 74- Chute de la TAH     - au massage du sinus G:       oui          non    
       ≥ 50 mmHg:      - au massage du sinus D:       oui          non    
        - au Valsalva:         oui          non    
 Autre anomalie ECG pendant manoeuvres:  .......................................... 
 75- Evénement compressif sur la carotide:         oui          non    
 
 Î Syncope sur dysfonction du sinus ou Valsalva (73,74, m 75 = positif) 
 
 
Manoeuvre de Valsalva: 
Doit être conduit sous monitoring ECG avec tracé. 
 
 
Massage du sinus carotidien: 
Inclure le tracé ECG (ou copie) des manoeuvres avec ce questionnaire. 
 
 N.B Si l’une (ou plus) des conditions suivantes est présente, ne pas  
effectuer la manoeuvre: 
 a) bruits carotidiens (qui évoqueraient une maladie carotidienne); 
b) maladie cérébrovasculaire  préexistante; 
c) ischémie myocardique ou cérébral; 
d) antécédents de tachyarythmies ventriculaires; 
e) autre contre-indication. 
 
 Procédure: Le patient, connecté à un ECG continue, est mis en position de 
décubitus dorsal, le cou hypertendu et la tête tournée du côté opposé à celui en train 
d’être testé. La bifurcation carotidienne (2 à 3 cm sous l’angle mandibulaire, derrière 
le chef ant. du mm SCM) est légèrement touchée avec la portion palmaire des doigts 
pour détecter une réponse d’hypersensibilité. Si aucun changement du rythme 
cardiaque n’est observé, alors on procédera a l’application d’une pression plus ferme 
pendant environ 5 secondes. Bien que les 2 côtés doivent être testés, on ne doit pas 
procéder à un massage bilatéral simultané, et on attendra en conséquence 15 sec avant 
de procéder à la stimulation du côté opposé. 
 
N.B  Un matériel de réanimation (eg. atropine) doit être à disposition. Les 
complications du massage du sinus carotidien comprennent entre 
autres l’asystolie prolongée et la fibrillation ventriculaire. 
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ECG   ECG normal:    oui     non    
 
 Si non,    76- Asystolie ≥ 3" à L’ECG  oui     non    
      77- Bradycardie ≤ 35/min   oui     non    
      78- Bloc A-V II° type 2   oui     non    
      79- Bloc A-V III°    oui     non    
      80- Tachycardie ventriculaire soutenue (≥ 30") 
        oui     non    
 
   Î Syncope sur arythmies: (76,77,78,79 ou 80 = positif) 
 
 
      81- Ancien infarctus   oui     non    
      82- Asystolie ≥ 2"-≤ 3"   oui     non    
      83- Bradycardie 35-40/min   oui     non    
      84- Bloc A-V II° type 1   oui     non    
      85- BB gauche ou droit   oui     non    
      86- Tachy. ventriculaire non soutenue (≤ 30") 
        oui     non    
      87- TSV > 30 sec, frequemce > 180/min oui     non    
      88- ESV multiples > 10/heure  oui     non    
      89- Sus ou sous-décalage du segment ST≥1mm 
        oui     non    
      Autre:  ....................................................................... 
 
   ÎAnomalies ECG non diagnostiques: 
       (si 81, 82, 83, 84, 85,86,87,88, ou 89 = positif) 
 
 
 
 
 Si sus ou sous-décalage du segment ST ≥ 1mm ou douleur d’angine de  
poitrine  Îrechercher une ischémie cardiaque aigue 
 
  90- Suspicion d’ischémie cardiaque aigue oui     non    
 
 
 
 Labo 
 
  91- Glycémie ≤ 3 mmol/l   oui     non    
  92- CPK totaux ≥ 200 U/l   oui     non    
  93- Hématocrite < 30 %   oui     non    
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D. Investigations en cas de diagnostic suspecté 
 
 
 Î A remplir si ces investigations sont fait au DUMC 
 
Investigations en cas de suspicion de maladie neurologique (Epilepsie, AIT?) 
 
  94- EEG     oui     non    
  95- Ct Scan cérébral    oui     non    
  96- Doppler-US    oui     non    
  97- Consultation Neurologie   oui     non    
  98- Autres: ................................................................................... 
 
 
 
 
Investigations en cas de suspicion de vol sous-clavier? 
 
  99- Bilan angiologique des MS  oui     non    
 
 
 
 
Investigations en cas de suspicion de sténose aortique ou d’hypertension 
artérielle pulmonaire? 
 
  100- Echographie cardiaque   oui     non    
 
 
 
 
Investigations en cas de diagnostic suspécté d’embolie pulmonaire? 
 
  101- Scintigraphi    oui     non    
  102- Angiographie pulmonaire  oui     non    
  103- Bilan angiologique des MI  oui     non    
  104- Dosage des D-dimères   oui     non    
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Suivi médical 
 Traitement de sortie: Date: ........................................... 
  185- Pace-Maker    oui     non    
  186- Défibrillateur implantable  oui     non    
  187- Antiarythmique    oui     non    
  188- Type d’antiarythmique:  ............................................... 
 
 Suivi à 3 mois:      oui     non    
  Date: ................................... Si non, raison:  ....................... 
  189- Va bien     oui     non    
  190- Récidive syncope   oui     non    
  191- Réhospitalisation   oui     non    
   Commentaires:  ............................................... 
  192- Décès     oui     non    
          Cause du décès:     1.-Mort subite 
         2.-Autre:  ....................... 
 
 Suivi à 6 mois:      oui     non    
  Date: ................................... Si non, raison:  ....................... 
  193- Va bien     oui     non    
  194- Récidive syncope   oui     non    
  195- Réhospitalisation   oui     non    
   Commentaires:  ............................................... 
  196- Décès     oui     non    
          Cause du décès:     1.-Mort subite 
         2.-Autre:  ....................... 
 
 Suivi à 12 mois:      oui     non    
  Date: ................................... Si non, raison:  ........................ 
  197- Va bien     oui     non    
  198- Récidive syncope   oui     non    
  199- Réhospitalisation   oui     non    
   Commentaires:  ............................................... 
  200- Décès     oui     non    
          Cause du décès:     1.-Mort subite 
         2.-Autre:  ....................... 
 
 Suivi à 18 mois:      oui     non    
  Date: ................................... Si non, raison:  ....................... 
  201- Va bien     oui     non    
  202- Récidive syncope   oui     non    
  203- Réhospitalisation   oui     non    
  Commentaires:   ............................................... 
  204- Décès     oui     non    
          Cause du décès:     1.-Mort subite 
         2.-Autre: .................................... 
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